High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$4K
$4,249
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
PCSA
P
Processa Pharmaceuticals, Inc.
Neal James R
• Director
Discretionary BuyΔOwn +2720.7%
2026-03-31
$2,000
|
||||||
| PCSA |
Processa Pharmaceuticals, Inc.
|
Director
Discretionary BuyΔOwn +2720.7%
|
2026-03-31 | $2,000 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $999 | P | Form 4 |
| AKTX |
Akari Therapeutics Plc
|
Director
Discretionary Buy
|
2025-12-16 | $1,250 | P | Form 4 |